蓝芩喉糖
Search documents
“春运”路上健康同行,扬子江药业集团携手甘肃广电温暖归乡路
Xin Lang Cai Jing· 2026-02-12 06:09
活动现场还设置了"心愿打卡区",邀请返乡游子们写下对新年的美好期盼。"马上考100分!""工作顺 利!"……一句句真挚的心愿,承载着对新一年的美好期盼。众多旅客积极参与,在感受健康关怀与新 春暖意的同时,满怀期待地踏上归家之路。 据了解,针对春运返乡高峰,扬子江已连续十余年向员工提供春节"爱心大巴"返乡专线,切实解决他们 返乡难的困扰。如今,这份温暖的春运关怀正从企业内部延伸至社会大众,让更多人在归家途中感受到 健康与温情。 2026年新春佳节将至,回家成为每个人最温暖的期待。一年一度的"春运"正式拉开序幕,一场暖心的公 益行动也在甘肃省各大交通枢纽内开展。近日,扬子江药业集团(以下简称"扬子江")联合甘肃省广播 电视总台广播传媒中心正式启动"平安幸福年,温暖回家路"公益活动,以线上线下融合发力的方式,为 春运注入健康暖流,用实际行动护航群众温暖回家。 作为本次公益活动的主办方之一,扬子江聚焦返乡群众出行需求,将暖心服务送到群众身边。龙凤堂黄 芪精、蓝芩喉糖等健康产品被送进各大交通枢纽车站,作为健康礼包,送给返乡旅客。同时,通过线上 实时连线,联动客运、高速公路、出租网约及汽车租赁等交通运输行业的一线工作者, ...
守正创新 让中医好方变好药
Ren Min Ri Bao· 2025-07-07 21:55
Core Viewpoint - The innovative traditional Chinese medicine (TCM) product Yiqi Tongqiao Wan has successfully completed phase III clinical trials and is now available for treating allergic rhinitis, with plans for a large-scale real-world study involving 10,000 samples to validate its clinical efficacy [1][3]. Group 1: Product Development and Efficacy - Yiqi Tongqiao Wan is developed by integrating modern medicinal components from the effective formula "Allergy Decoction" and employs modern pharmaceutical techniques [2]. - Clinical trial results show significant efficacy, with a nasal discharge symptom disappearance rate of 52.65% and a tear symptom disappearance rate of 80.97%. Additionally, 30% of patients did not experience a recurrence of rhinitis within a year after two weeks of treatment [3]. Group 2: Quality Control and Technological Integration - The quality of raw materials is crucial for modern pharmaceutical companies, and Yiqi Tongqiao Wan's 14 ingredients are sourced from high-quality regions and standardized cultivation bases [5]. - The production process utilizes digital technology for quality traceability throughout the entire supply chain, enhancing the stability and uniformity of the extract's quality [5][6]. Group 3: Market Expansion and Cultural Promotion - The company is expanding the application of TCM by developing diverse product lines, including health foods and beverages that incorporate TCM ingredients [8]. - Efforts to promote TCM culture include public health services and community engagement activities, aiming to enhance public understanding and acceptance of TCM [8].
扬子江药业董事长徐浩宇:助推做自己健康第一责任人的理念深入人心
Sou Hu Cai Jing· 2025-05-19 02:26
Core Viewpoint - Yangtze River Pharmaceutical Group is focusing on transitioning from disease treatment to disease prevention and intervention through technological, product, and ecological innovations, aiming to enhance public health awareness and management [1][3][4] Group 1: Health Management and Education - The company emphasizes the need for a systematic understanding of disease prevention among the public, advocating for a proactive approach to health management [3] - Initiatives include internal health education programs and external health science communication through various media formats, aiming to make health knowledge more accessible [3][4] - The company is addressing common health issues among young people, such as sleep deprivation, by promoting understanding of disease causes and encouraging active health management [3] Group 2: Product Development and Market Expansion - Yangtze River Pharmaceutical Group is accelerating the development of health products that integrate traditional Chinese medicine with daily nutrition, such as herbal candies and health coffees [4] - The company plans to expand its traditional Chinese medicine planting bases from 80 to 300 within five years to meet the growing demand for health products [4] Group 3: Integrated Health Ecosystem - The company aims to create a comprehensive health ecosystem that includes medicine, healthcare, nutrition, and wellness tourism, promoting a holistic approach to health [5][6] - The brand philosophy emphasizes individual responsibility for health, aligning with the goal of making health management a habitual practice for everyone [5] - Yangtze River Pharmaceutical Group is leveraging cultural elements to enhance the health industry and is committed to collaborative innovation across academia and industry [6]
扬子江药业集团:锚定世界一流企业 持续追求卓越品牌
Zhong Guo Zhi Liang Xin Wen Wang· 2025-05-08 08:39
Core Viewpoint - Brand building is essential for high-quality development, and Yangtze River Pharmaceutical Group aims to create world-class health brands through its commitment to excellence and innovation [1][6]. Group 1: Brand Development - Yangtze River emphasizes its brand proposition of "Health for Everyone, Everyone for Health" and aims to develop three major brands: "Yangtze River" for Western medicine, "Longfengtang" for traditional Chinese medicine, and "Huyou" for health products [1]. - The company has achieved significant recognition in quality management, winning the "EFQM Global Award" and receiving a "Seven-Star Certification" from the European Foundation for Quality Management [2][3]. Group 2: Quality Management - Yangtze River has won the national quality management award for 20 consecutive years and has received 31 international quality gold awards, showcasing its commitment to quality [3]. - The company has multiple production facilities certified by EU GMP and the US FDA, enhancing its brand recognition in international markets [3]. Group 3: Innovation - Yangtze River is actively engaged in research and development, with over 100 drugs in the pipeline, including more than 20 new drugs in clinical application stages [4]. - The company has launched several health products and is focusing on digital transformation and smart manufacturing to enhance its competitive edge [4]. Group 4: Corporate Responsibility - Yangtze River integrates public welfare into its brand identity, supporting community health initiatives and promoting fitness through events like the Taizhou Marathon [5]. - The company has established 80 standardized planting bases for traditional Chinese medicine, ensuring product quality and traceability throughout the supply chain [5]. Group 5: Strategic Vision - Yangtze River is building a "3+N" brand system to provide comprehensive health services across the entire lifecycle, aligning with the "Healthy China" strategy [6].